# Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/multicentre-randomised-phase-iii-study-comparing-the-same-dose-and-schedule-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andrea Martoni,Antonella Marino,Francesca Sperandi,S. Giaquinta,Francesca Di Fabio,Barbara Melotti,M. Guaraldi,Giuseppe Palomba,P. Preti,Antonino Petralia,Fabrizio Artioli,Vincenzo Picece,A. Farris,LG Mantovani |
| Citations | 73 |
| DOI | 10.1016/j.ejca.2004.08.029 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2043173598 |
| PMID | 15617993 |
| Type | article |
| Year | 2004 |

## Paper authors

- [Giuseppe Palomba](https://scholariq.org/researchers/giuseppe-palomba/)
- [Antonino Petralia](https://scholariq.org/researchers/antonino-petralia/)

## Paper journal

- [European Journal of Cancer](https://scholariq.org/journals/european-journal-of-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.